SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros is trending following the FDA approval of YARTEMLEA, making it the first and only approved therapy for the life-threatening transplant-associated thrombotic microangiopathy (TA-TMA). The community is celebrating this significant milestone, with discussions centered on the stock's perceived undervaluation, potential for a short squeeze, and heightened speculation around a buyout, especially given a prior licensing deal with Novo Nordisk.

Biohaven Ltd. is a global clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies for people with neurological and neuropsychiatric diseases. The company was founded on May 2, 2022 and is headquartered in New Haven, CT.

Biohaven Ltd

Biohaven Pharmaceutical Holding Company Ltd

Biohaven is trending following a recent clinical trial failure for its depression drug, a development released during a holiday period that drew community criticism for its timing. However, investor attention is quickly shifting to the company's robust pipeline, particularly upcoming data for its epilepsy, obesity, and oncology programs. Significant insider buying after a recent offering has also fueled renewed confidence, signaling a belief in future growth despite prior regulatory setbacks.

Dynavax Technologies Corp. is a biopharmaceutical company, which engages in the provision of discovery, development, and commercialization of novel vaccines and immuno-oncology therapeutics. Its product includes HEPLISAV-B, which prevents infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older. The company was founded by Lawrence M. Lichtenstein, Dennis A. Carson, and Eyal Raz on August 29, 1996 and is headquartered in Emeryville, CA.

Dynavax Technologies Corp.

Dynavax is trending sharply higher following the announcement of its acquisition by Sanofi, significantly boosting Sanofi's adult immunization portfolio with Heplisav-B and a promising shingles vaccine candidate. While many long-term investors express disappointment over the agreed price, viewing it as an undervaluation, others are relieved to see an exit after years of holding amid prior discussions about management's performance and shareholder value.

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Tempus AI Inc. - Ordinary Shares - Class A

Tempus AI Inc

Tempus AI is a trending topic after reporting robust earnings, showcasing a critical milestone with its first positive adjusted EBITDA, coupled with increased revenue guidance that signals continued growth in AI-driven precision medicine. Despite these strong results and several analyst upgrades, the community is actively debating recent price volatility, with many expressing long-term conviction in the company's AI-driven healthcare platform while others point to "sell the news" dynamics and market manipulation.

Shiba Inu (SHIB) is a meme token which began as a fun currency and has now transformed into a decentralized ecosystem. During the initial launch, 50% of the supply was allocated into Vitalik Buterin's ethereum wallet.   As a result of that, Vitalik proceeded to donate 10% of his SHIB holdings to a COVID-19 relief effort in India and the remaining 40% is burnt forever. That donation was worth about $1 billion at that time, which makes it one of the largest donation ever in the world.  What is the Shiba Inu community working on right now? The Shiba Inu team launched a decentralized exchange called Shibaswap with 2 new tokens, LEASH and BONE. LEASH is a scarce supply token that is used to offer incentives on Shibaswap. BONE is the governance token for holders to vote on proposals on Doggy DAO.

Shiba Inu

Shiba Inu (SHIB) is trending with highly polarized community sentiment as investors debate its immediate future. Many loyal holders view recent price action as a prime accumulation opportunity, anticipating a strong rally, while a vocal contingent labels it a "scam" or "shitcoin" and questions its underlying value. This prominent meme coin continues to generate significant conversation regarding its potential amidst broader market volatility.

Bank of Montreal engages in the provision of banking and financial services to individuals and institutions. It operates through the following segments: Canadian Personal and Commercial Banking (Canadian P&C), United States Personal and Commercial Banking (U.S. P&C), BMO Wealth Management, BMO Capital Markets, and Corporate Services. The company was founded by Robert Armour, John C. Bush, Austin Cuvillier, George Garden, Horatio Gates, James Leslie, George Moffatt, John Richardson and Thomas A. Turner on June 23, 1817 and is headquartered in Toronto, Canada.

Bank of Montreal - MicroSectors Gold Miners 3X Leveraged ETN

GDXU, a 3x leveraged ETN for gold miners, is experiencing intense conversation as the community debates its parabolic ascent and sharp corrections. Fueled by gold's rally to new highs, central bank buying, and concerns over inflation and geopolitical instability, traders are keenly discussing entry points, profit-taking strategies, and the overall bullish outlook for precious metals, despite its inherent volatility.

Himax Technologies, Inc. is a semiconductor solution provider dedicated to display imaging processing technologies. It operates through the Driver Integrated Circuit and Non-Driver Products segments. The company's products include display drivers, timing controllers, wafer level optics, video and display technology solutions, liquid crystal over silicon silicon, complementary metal-oxide semiconductor image sensor, and power integrated circuit. Its products used in TVs, laptops, monitors, mobile phones, tablets, digital cameras, car navigation, virtual reality (VR) devices and many other consumer electronics devices. Himax Technologies was founded by Biing Seng Wu and Jordan Wu on June 12, 2001 and is headquartered in Tainan, Taiwan.

Himax Technologies - ADR

Himax Technologies, Inc.

Himax Technologies is gaining attention for its central role in Co-Packaged Optics (CPO) and Silicon Photonics, supplying crucial components for TSMC's COUPE platform, which is integral to advanced AI chips from major players like NVIDIA and AMD. The community is highly engaged, discussing the immense future revenue potential from this technology and emerging AR/AI applications, though some express impatience regarding the timeline for these innovations to significantly impact the company's financial results.

Aduro Clean Technologies, Inc. engages in the manufacture of oils and specialty chemicals using waste plastics. It focuses on hydrochemolytic technology to transform post-consumer polymer waste into a resource for the circular economy. It also develops a novel chemical conversion process to transform waste plastics and low grade renewable oils into renewable fuels and specialty chemicals. The company was founded on January 10, 2018 by Ofer Vicus and William Marcus Trygstad and is headquartered in Sarnia, Canada.

Aduro Clean Technologies Inc

Aduro Clean Technologies is trending as recent developments, including the closure of a public offering and significant technical validations like graduating Shell's GameChanger program and successful steam-cracking trials, energize investors. Community discussion highlights the company's de-risking milestones and vast market potential for its Hydrochemolytic technology, though skeptics continue to challenge its economic viability and commercial pathway.

Spruce Biosciences, Inc. is a biopharmaceutical company, which engages in developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need. The company was founded on November 13, 2014 and is headquartered in South San Francisco, CA.

Spruce Biosciences Inc

Spruce Biosciences is trending following the FDA's Breakthrough Therapy Designation for its rare neurological disease therapy and recent analyst upgrades. This major catalyst has sparked intense community debate, with bulls anticipating further upside due to its low float and potential acquisition interest, while others express concern over recent dilution from a private placement and its small target patient population.

The Cosmos network consists of many independent, parallel blockchains, called zones, each powered by classical Byzantine fault-tolerant (BFT) consensus protocols like Tendermint. Some zones act as hubs with respect to other zones, allowing many zones to interoperate through a shared hub. The architecture uses classic BFT and Proof-of-Stake algorithms, instead of Proof-of-Work. Cosmos can interoperate with multiple other applications and cryptocurrencies, something other blockchains can’t do well. By creating a new zone, you can plug any blockchain system into the Cosmos hub and pass tokens back and forth between those zones, without the need for an intermediary.  While the Cosmos Hub is a multi-asset distributed ledger, there is a special native token called the atom. ATOM have three use cases: as a spam-prevention mechanism, as staking tokens, and as a voting mechanism in governance.  As a spam prevention mechanism, ATOM are used to pay fees. The fee may be proportional to the amount of computation required by the transaction, similar to Ethereum’s concept of “gas”. Fee distribution is done in-protocol and a protocol specification is described here.  As staking tokens, ATOM can be “bonded” in order to earn block rewards. The economic security of the Cosmos Hub is a function of the amount of ATOM staked. The more ATOM that are collateralized, the more “skin” there is at stake and the higher the cost of attacking the network. Thus, the more ATOM there are bonded, the greater the economic security of the network.  Atom holders may govern the Cosmos Hub by voting on proposals with their staked ATOM.

Cosmos

ATOM is trending as community discussion intensifies around its 'Internet of Blockchains' model versus emerging, compliance-first infrastructure like Keeta, which boasts high throughput for institutional finance. Many holders are debating ATOM's long-term value and recent price stagnation, even as a significant tokenomics redesign aims to shift towards a revenue-based model, highlighting a broader market focus on both foundational interoperability and specialized, high-performance settlement layers.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Best Value Stocks To Research - December 24th

Invesco QQQ, AST SpaceMobile, Rocket Lab, CoreWeave, and ProShares UltraPro Short QQQ are the five Value stocks to watch today, according to MarketBeat's stock screener tool. Value stocks are shares...

Promising Large Cap Stocks To Keep An Eye On - December 24th

Tesla, NVIDIA, Invesco QQQ, Micron Technology, and Apple are the five Large Cap stocks to watch today, according to MarketBeat's stock screener tool. Large-cap stocks are shares of companies with...

<ul class="summary-bullets"><li>The list included companies from healthcare, consumer, and banking.</li><li>The stocks were among the most discussed names during the Christmas Eve session.</li><li>Trading took place during a shortened U.S. market session.</li></ul>U.S. stocks finished the shortened Christmas Eve session on a firm footing, with the S&amp;P 500 touching a fresh record as investors leaned into expectations for interest-rate cuts in the year ahead.&nbsp;Optimism was supported by data showing the U.S. economy expanded at its fastest pace in two years during the third quarter, while a drop in new jobless claims on Wednesday pointed to continued resilience in the labor market.The&nbsp;<a href="https://stocktwits.com/symbol/SPY">SPDR S&amp;P 500 ETF</a> (SPY), which mirrors the S&amp;P 500 index, was up 0.5% at the time of writing, while the&nbsp;<a href="https://stocktwits.com/symbol/QQQ">Invesco QQQ Trust</a> (QQQ), which mirrors the Nasdaq 100 index, gained 0.3%. The&nbsp;<a href="https://stocktwits.com/symbol/DIA">SPDR Dow Jones Industrial Average ETF Trust</a> (DIA), which tracks the Dow Jones Industrial Average, rose 0.6%.<h3 class="st-heading-3">Here’s a look at the names that drew the most buzz:</h3><h2 class="st-heading-2">Omeros Corporation (OMER)</h2>Omeros surged 67% in Wednesday’s midday session following its long-awaited&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/omeros-stock-jumps-premarket-after-fda-approves-first-drug-for-rare-transplant-complication/cLesxhYREvL">FDA approval for Yartemlea</a>, the first and only treatment approved for the rare and often-fatal transplant complication TA-TMA. The green light paves the way for a U.S. launch in the first half of next year.<a href="https://stocktwits.com/symbol/OMER">OMER stock</a> is up 69% year-to-date.<h2 class="st-heading-2">Nike (NKE)</h2>Nike climbed 5% in Wednesday’s midday session after a regulatory filing showed board member&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/nike-stock-pops-after-hours-as-apple-s-tim-cook-buys-nearly-3-m-in-shares-amid-turnaround-effort/cLeqcjTREHl">Tim Cook made a nearly $3 million</a> open-market purchase of the stock. The buy stood out as a show of confidence as the company navigates a multi-year turnaround under returning CEO Elliott Hill, even as tariffs and a cautious holiday outlook continue to weigh on sentiment.<a href="https://stocktwits.com/symbol/NKE">NKE stock</a> is up 5% year-to-date.<h2 class="st-heading-2">Citigroup (C)</h2>Citigroup rose 2% in Wednesday’s midday session and extended a powerful rally, pushing&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/citi-stock-hits-highest-levels-since-2008-factors-at-play/cLetR7ZREvo">shares to levels last seen since 2008</a>. The stock has logged gains in most recent sessions as investors responded to upbeat brokerage calls, easing regulatory pressure and a sweeping internal overhaul aimed at boosting returns and simplifying the business.C<a href="https://stocktwits.com/symbol/NVO"> stock</a> is up 2% year-to-date.<h2 class="st-heading-2">Dynavax Technologies (DVAX)</h2>Dynavax jumped 38% in Wednesday’s midday session after&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-did-dynavax-stock-surge-38-in-premarket-today/cLesA4mREHU">Sanofi agreed to buy the vaccine maker</a> for $2.2 billion in cash. The deal adds Dynavax’s hepatitis B vaccine and pipeline assets to Sanofi’s portfolio and marked one of the day’s clearest takeover-driven moves.<a href="https://stocktwits.com/symbol/DVAX">DVAX stock</a> is up 38% year-to-date.<h2 class="st-heading-2">Agios Pharmaceuticals (AGIO)</h2>Agios rallied 18% in Wednesday’s midday session after the&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-did-agio-stock-surge-14-today/cLesxI9REvh">FDA approved Aqvesme</a>, an oral therapy for anemia in adults with alpha- or beta-thalassemia. The approval, backed by late-stage trial data, positions Aqvesme as the only FDA-approved treatment across both transfusion-dependent and non-dependent forms of the disease, with a U.S. launch expected next month.<a href="https://stocktwits.com/symbol/AGIO">AGIO stock</a> is up 18% year-to-date.For updates and corrections, email newsroom[at]stocktwits[dot]com.

With holiday festivities officially beginning in New York with the Thanksgiving Day Parade on Thursday, Santa Claus and elves visited the New York Stock Exchange (NYSE) on November 26, 2025. (Photo by Spencer Platt/Getty Images)

Retail’s Christmas Eve Watchlist: Omeros, Nike, Citi, Dynavax And Agios Spark Most Market Chatter

The stocks were tracked during the shortened Christmas Eve session across healthcare, consumer, and banking.

Equity

<ul class="summary-bullets"><li>The Santa Claus rally, which refers to the stock market’s tendency to rise during the final five trading days in December and the first two trading days of the new year, is now underway.</li><li>Ryan Detrick, Chief Market Strategist at Carson Group, stated in his latest note that the Santa Claus rally is more likely than not to take place this year.</li><li>Analysts at Schwab noted that investors will gauge the “durability” of a modest Santa Claus rally, with the strong Q3 GDP print on their minds.</li></ul>The S&amp;P 500 index hit a fresh all-time high on Wednesday, kicking off the Santa Claus rally a day after scoring a record high following a better-than-expected third-quarter (Q3) GDP print.All three major indexes, the Dow Jones Industrial Average, the S&amp;P 500, and the Nasdaq Composite, were in the green at the time of writing.<figure class="table"><table class="ck-table-resized" style=";"><colgroup><col style="width:25%;"><col style="width:25%;"><col style="width:25%;"><col style="width:25%;"></colgroup><tbody><tr><td style="border:1pt solid #000000;padding:5pt;vertical-align:top;">Index</td><td style="border:1pt solid #000000;padding:5pt;vertical-align:top;">Latest Quote</td><td style="border:1pt solid #000000;padding:5pt;vertical-align:top;">Day’s Change</td><td style="border:1pt solid #000000;padding:5pt;vertical-align:top;">YTD Change</td></tr><tr><td style="border:1pt solid #000000;padding:5pt;vertical-align:top;">Dow Jones Industrial Average</td><td style="border:1pt solid #000000;padding:5pt;vertical-align:top;">48,685.75</td><td style="border:1pt solid #000000;padding:5pt;vertical-align:top;">0.5%</td><td style="border:1pt solid #000000;padding:5pt;vertical-align:top;">14.43%</td></tr><tr><td style="border:1pt solid #000000;padding:5pt;vertical-align:top;">S&amp;P 500</td><td style="border:1pt solid #000000;padding:5pt;vertical-align:top;">6,929.59</td><td style="border:1pt solid #000000;padding:5pt;vertical-align:top;">0.29%</td><td style="border:1pt solid #000000;padding:5pt;vertical-align:top;">17.82%</td></tr><tr><td style="border:1pt solid #000000;padding:5pt;vertical-align:top;">Nasdaq Composite</td><td style="border:1pt solid #000000;padding:5pt;vertical-align:top;">23,598.79</td><td style="border:1pt solid #000000;padding:5pt;vertical-align:top;">0.16%</td><td style="border:1pt solid #000000;padding:5pt;vertical-align:top;">22.2%</td></tr></tbody></table></figure><h2 class="st-heading-2">Santa Claus Rally Begins</h2>The Santa Claus rally, which refers to the stock market’s tendency to rise during the final five trading days in December and the first two trading days of the new year, is now underway.The seven-day period begins on Wednesday and runs through January 5.Ryan Detrick, Chief Market Strategist at Carson Group, stated in his latest note that the Santa Claus rally is more likely than not to take place this year.“Historically, it turns out these seven days indeed have been quite jolly, as no seven-day combo is more likely to be higher (up 77.3% of the time), and only two combos have a better average return for the S&amp;P 500 than the 1.27% average return during the official Santa Claus Rally period,” he said.Analysts at Schwab noted that investors will gauge the “durability” of a modest Santa Claus rally, with the strong Q3 GDP print on their minds.<h2 class="st-heading-2">S&amp;P 500 Target</h2>Market experts expect the S&amp;P 500 index to continue to gain in 2026, though the forecast range is wide, with&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/bofa-savita-subramanian-says-sp500-will-end-2026-at-7100-heres-what-citi-and-oppenheimer-expect/cLe4eUbREol">targets</a> ranging from 7,100 to 8,100.Bank of America Securities’ head of U.S. equity and quantitative strategy, Savita Subramanian, believes that the S&amp;P 500 index will end 2026 at 7,100, implying an upside of nearly 2.5% from current levels.Other firms, such as Citi and Oppenheimer, are more bullish on the S&amp;P 500 index's outlook heading into 2026. While Citi has a target of 7,700, Oppenheimer expects the S&amp;P 500 index to rally nearly 17% to end 2026 at 8,100.<h2 class="st-heading-2">Outlook For 2026 For Risk Assets</h2>Jeremy Siegel, professor emeritus of finance at the University of Pennsylvania’s Wharton School of Business,&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/wharton-jeremy-siegel-2026-good-year-for-risk-assets/cLeplcAREuj">stated</a> on Tuesday that 2026 has the necessary ingredients to be a good year for risk assets.However, for his prediction to materialize, Siegel stated that Washington will have to avoid self-inflicted disruptions and that productivity continues to hold up.“One underappreciated tailwind into year-end is productivity: if productivity holds up while nominal demand cools, inflation can fall without the economy needing to break. That’s the best possible mix for both equities and longer-duration assets,” he said.At the time of writing, the&nbsp;<a href="https://stocktwits.com/symbol/SPY">SPDR S&amp;P 500 ETF</a> (SPY), which tracks the S&amp;P 500 index, was up 0.28%, the&nbsp;<a href="https://stocktwits.com/symbol/QQQ">Invesco QQQ Trust ETF</a> (QQQ) gained 0.19%, while the&nbsp;<a href="https://stocktwits.com/symbol/DIA">SPDR Dow Jones Industrial Average ETF Trust</a> (DIA) rose 0.52%. Retail sentiment around the S&amp;P 500 ETF on Stocktwits was in the ‘bullish’ territory.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/christmas-2025-january-fed-rate-cut-odds-sink-after-q3-gdp-blowout/cLesCwVREvj">Christmas 2025: January Fed Rate Cut Odds Sink After Q3 GDP Blowout</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Traders work on the floor of the New York Stock Exchange during morning trading on May 12, 2025 in New York City. (Photo by Michael M. Santiago/Getty Images)

Wall Street Turns Jolly Heading Into Christmas: S&P 500 Notches New Record As Santa Claus Rally Begins

All three major indexes, the Dow Jones Industrial Average, the S&P 500, and the Nasdaq Composite, were in the green at the time of writing.

<ul class="summary-bullets"><li>According to data from the CME FedWatch tool, the probability of a 25-basis-point rate cut in January is now 13.3%, down from 24.4% a week ago.</li><li>Similarly, the odds of a 25 bps cut in March fell to 40.7%, from 44.4% a week ago.</li><li>Unlike in the Trump administration, there is less consensus among market experts regarding the Fed’s monetary policy direction in 2026.</li></ul>The Federal Reserve’s monetary policy direction heading into 2026 is in focus after the unexpectedly strong U.S. Gross Domestic Product (GDP) growth in the third quarter (Q3), bolstered by consumer spending, exports, and government spending.Following the conclusion of the Federal Open Market Committee’s (FOMC) meeting earlier this month, the central bank penciled just one rate cut in 2026.<h2 class="st-heading-2">What Are The Markets Expecting?</h2>While Trump administration officials&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/treasury-official-fed-rate-cuts-2026-gdp-growth-3-next-year/cLesMyrREvE">continue</a> to back lower rates, market expectations point to the Fed pausing next month. According to data from the CME FedWatch&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.cmegroup.com/markets/interest-rates/cme-fedwatch-tool.html">tool</a>, the probability of a 25-basis-point rate cut in January is now down to 13.3%, from 24.4% a week ago. Similarly, the odds of a 25 bps cut in March fell to 40.7%, from 44.4% a week ago.This follows three consecutive 25-basis-point rate cuts in the September, October, and December FOMC meetings.<h2 class="st-heading-2">Market Experts Divided</h2>Unlike in the Trump administration, there is less consensus among market experts.Collin Martin, head of fixed income research and strategy at the Schwab Center for Financial Research, stated in a recent note that the strong GDP print could prevent the Fed from cutting rates more than twice next year.“Strong growth like this should prevent the Fed from cutting much more than one or two times next year and is one more reason that long-term yields should stay elevated,” Martin said.In contrast, Erik Bregar, director of FX and precious metals risk management at Silver Gold Bull, told&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.reuters.com/world/asia-pacific/us-dollar-trims-losses-after-stronger-than-expected-growth-data-2025-12-23/">Reuters</a> that the Fed may be forced to cave in to calls for rate cuts.“The market wants cuts. And the odds are that we're going to get a dovish Fed chair that will try to make that happen,” he said, according to the report.Chris Zaccarelli, chief investment officer at Northlight Asset Management, said inflation could return as a threat, according to a <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://apnews.com/article/economy-gdp-growth-spending-inflation-c660fb571421c48d2e91fa18bf4633d7">report</a> by The Associated Press. “If the economy keeps producing at this level, then there isn’t as much need to worry about a slowing economy,” he said.&nbsp;<h2 class="st-heading-2">Who’s Backing Cuts?</h2>From Fed Governor Stephen Miran to Treasury official Joe Lavorgna and President Donald Trump, several voices are calling for further rate cuts next year.Miran&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/fed-miran-warns-recession-risk-if-rates-are-not-cut/cLeFjX1REMK">warned</a> earlier this week that if the central bank does not lower policy rates further, there could be a rise in recession risks.Lavorgna said that if the U.S. economy continues to grow at 3% in 2026 with supply-side gains, that will result in lower inflation. In this light, if the Fed keeps interest rates steady, that will result in a restrictive monetary policy.“So, the Fed can continue to lower rates. The Fed should lower rates based on its own estimates of where our star is, the neutral rate,” he added.President Trump stated in a&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://truthsocial.com/@realDonaldTrump/posts/115770165868454573">post</a> on Truth Social on Tuesday that he wants the next Fed Chair to lower interest rates if the markets are doing well.“I want to have a Market the likes of which we haven’t had in many decades, a Market that goes up on good news, and down on bad news, the way it should be, and the way it was,” he said, while adding that inflation will take care of itself.Meanwhile, U.S. equities gained in Wednesday’s opening trade. At the time of writing, the&nbsp;<a href="https://stocktwits.com/symbol/SPY">SPDR S&amp;P 500 ETF</a> (SPY), which tracks the S&amp;P 500 index, was up 0.21%, the&nbsp;<a href="https://stocktwits.com/symbol/QQQ">Invesco QQQ Trust ETF</a> (QQQ) gained 0.09%, while the&nbsp;<a href="https://stocktwits.com/symbol/DIA">SPDR Dow Jones Industrial Average ETF Trust</a> (DIA) rose 0.43%. Retail sentiment on Stocktwits regarding the S&amp;P 500 ETF was in the ‘bullish’ territory.The&nbsp;<a href="https://stocktwits.com/symbol/DIA">iShares 7-10 Year Treasury Bond ETF</a> (IEF) was up 0.12% at the time of writing.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/us-jobless-claims-report-december-20-2025-week/cLesDVTREva">Jobless Claims Unexpectedly Fall For Second Consecutive Week</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, The Federal Reserve System logo displayed on a smartphone. 

Christmas 2025: January Fed Rate Cut Odds Sink After Q3 GDP Blowout

While Trump administration officials continue to back lower rates, market expectations point to the Fed taking a pause next month.

Top-Performing International ETFs of 2025

International ETFs like VEA, EZU & EEM outshone U.S. peers in 2025 as cheaper valuations, diversified exposure, and stimulus measures drove substantial gains.

<ul class="summary-bullets"><li>The four-week moving average for jobless claims, which smoothens weekly volatility, fell by 750 to 216,750.</li><li>Continuing claims, which refer to the number of people claiming unemployment benefits beyond the first week, hovered near 1.92 million for the week ended December 13, increasing by 38,000 over the previous week.</li><li>The largest increase in claims was in Rhode Island at 452, followed by West Virginia at 325, whereas the largest decrease was in Illinois at 7,242 and New York at 5,720.</li></ul>Weekly jobless claims fell more than expected for the second consecutive week, according to data released a day early by the U.S. Department of Labor due to Christmas.Jobless claims fell by 10,000 to 214,000 in the week ended December 20. This was lower than a Dow Jones estimate of 224,000, as&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.marketwatch.com/economy-politics/calendar">cited</a> by MarketWatch. The four-week moving average for jobless claims, which smooths weekly volatility, fell by 750 to 216,750.This is the second consecutive weekly decline in jobless claims – benefit applications fell by 13,000 last week to 224,000, according to Labor Department data.Economists expected the claims to stand at 225,000, according to a Dow Jones estimate.<h2 class="st-heading-2">Continuing Claims Rise</h2>Continuing claims, which refer to the number of people claiming unemployment benefits beyond the first week, hovered near 1.92 million for the week ended December 13, increasing by 38,000 over the previous week.The largest increase in claims was in Rhode Island at 452, followed by West Virginia at 325, whereas the largest decrease was in Illinois at 7,242 and New York at 5,720.<h2 class="st-heading-2">Resilient Economy</h2>The U.S. economy&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/us-gdp-q3-december-2025/cLep8gzREuU">continues</a> to show resilience, with the Gross Domestic Product (GDP) growing at an annualized rate of 4.3% in the third quarter (Q3), beating Wall Street estimates of 3.2%.However, Mohamed El-Erian, Chief Economic Advisor at Allianz,&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/el-erian-employment-decoupling-from-gdp-due-to-ai/cLeiHPbREs4">warned</a> last week that the relationship between employment and GDP is under strain.“Historically, robust economic growth has been inextricably linked to strong job creation. But this relationship appears to be under pressure, meaning that growth in 2026 may be accompanied by a relatively stagnant labor market,” he said.Meanwhile, U.S. equities traded in the green on Wednesday morning. At the time of writing, the&nbsp;<a href="https://stocktwits.com/symbol/SPY">SPDR S&amp;P 500 ETF</a> (SPY), which tracks the S&amp;P 500 index, was up by 0.01%, the&nbsp;<a href="https://stocktwits.com/symbol/QQQ">Invesco QQQ Trust ETF</a> (QQQ) gained 0.03%, while the&nbsp;<a href="https://stocktwits.com/symbol/DIA">SPDR Dow Jones Industrial Average ETF Trust</a> (DIA) rose 0.1%. Retail sentiment around the S&amp;P 500 ETF on Stocktwits was in the ‘bullish’ territory.The&nbsp;<a href="https://stocktwits.com/symbol/IEF">iShares 7-10 Year Treasury Bond ETF</a> (IEF) was up by 0.12% at the time of writing.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/rptx-stock-soars-after-gilead-agrees-to-acquire-repare-investigational-cancer-treatment/cLesuB8REvI">RPTX Stock Soars Pre-Market After Gilead Agrees To Acquire Investigational Cancer Drug</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Job seekers stand in line at the Wyndham Destinations booth during the Mega JobNewsUSA South Florida Job Fair held in the Amerant Bank Arena on April 30, 2025. (Photo by Joe Raedle/Getty Images)

Jobless Claims Unexpectedly Fall For Second Consecutive Week

According to data released by the U.S. Department of Labor on Wednesday, jobless claims fell by 10,000 to 214,000 in the week ended December 20.

Invesco QQQ $QQQ Shares Acquired by McClarren Financial Advisors Inc.

McClarren Financial Advisors Inc. raised its position in shares of Invesco QQQ (NASDAQ:QQQ - Free Report) by 122.6% in the 3rd quarter, according to the company in its most recent disclosure with the...

Plancorp LLC Cuts Holdings in Invesco QQQ $QQQ

Plancorp LLC lowered its stake in Invesco QQQ (NASDAQ:QQQ - Free Report) by 24.4% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC...

<ul class="summary-bullets"><li>Making the case for rate cuts, Lavorgna stated that, coupled with lower rates and manufacturing investments, the U.S. will “build a whole lot more next year.”</li><li>He added that the fourth-quarter growth could come in around 3%, which would put the 2025 growth at just under 3%.</li><li>The International Monetary Fund’s latest outlook pegs the U.S. economy’s growth at 2% in 2025 and 2.1% in 2026.</li></ul>Joe Lavorgna, counselor to Treasury Secretary Scott Bessent, reportedly backed further interest rate cuts in 2026 while expecting the U.S. economy to grow by about 3% next year.During an&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://finance.yahoo.com/news/treasury-official-the-fed-can-cut-rates-next-year-even-in-the-face-of-strong-growth-120041507.html">interview</a> with Yahoo Finance, Lavorgna stated that the Federal Reserve can cut rates next year even as the U.S. economy continues to show resilience, after a report by the Bureau of Economic Analysis showed that the Gross Domestic Product (GDP) grew at an annualized rate of 4.3%, higher than the Dow Jones forecast of 3.2%.He added that if the U.S. economy continues to grow at 3% in 2026 with supply-side gains, that will result in lower inflation. In this light, if the Fed keeps interest rates steady, that will result in a restrictive monetary policy.“So, the Fed can continue to lower rates. The Fed should lower rates based on its own estimates of where our star is, the neutral rate, and based on the fact that interest-sensitive activity is still extraordinarily weak, and that's where monetary policy has the most impact,” Lavorgna said, according to the report.According to data from the CME FedWatch&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.cmegroup.com/markets/interest-rates/cme-fedwatch-tool.html">tool</a>, the probability of a 25-basis-point rate cut in January is now 13.3%, down from 24.4% a week ago.<h2 class="st-heading-2">The Case For Rate Cuts</h2>Making the case for rate cuts, Lavorgna stated that, coupled with lower rates and manufacturing investments, the U.S. will “build a whole lot more next year.”He added that the fourth-quarter (Q4) growth could come in around 3%, which would put the 2025 growth at just under 3%.The International Monetary Fund’s latest outlook pegs the U.S. economy’s growth at 2% in 2025 and 2.1% in 2026.<h2 class="st-heading-2">Trump’s Expectations From Fed Chair</h2>Reacting to the U.S. economy’s better-than-expected growth in the third quarter (Q3), President Donald Trump on Tuesday stated in a&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://truthsocial.com/@realDonaldTrump/posts/115770165868454573">post</a> on Truth Social that he wants the next Fed Chair to lower interest rates if the markets are doing well.“I want to have a Market the likes of which we haven’t had in many decades, a Market that goes up on good news, and down on bad news, the way it should be, and the way it was,” he said, while adding that inflation will take care of itself.Meanwhile, U.S. equities were mixed in Wednesday’s pre-market trade. At the time of writing, the&nbsp;<a href="https://stocktwits.com/symbol/SPY">SPDR S&amp;P 500 ETF</a> (SPY), which tracks the S&amp;P 500 index, was up 0.01%, the&nbsp;<a href="https://stocktwits.com/symbol/QQQ">Invesco QQQ Trust ETF</a> (QQQ) gained 0.03%, while the&nbsp;<a href="https://stocktwits.com/symbol/DIA">SPDR Dow Jones Industrial Average ETF Trust</a> (DIA) fell 0.05%. Retail sentiment around the S&amp;P 500 ETF on Stocktwits was in the ‘bullish’ territory.The&nbsp;<a href="https://stocktwits.com/symbol/DIA">iShares 7-10 Year Treasury Bond ETF</a> (IEF) was up 0.1% at the time of writing.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/us-equities-could-hit-new-highs-santa-claus-rally-says-ryan-detrick/cLeppGTREHd">Ryan Detrick Says Santa Rally Likely This Time After Not Showing Up For Past Two Years</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

The seal of the Federal Reserve is pictured before Fed Chairman Jerome Powell announced the Fed will leave interest rates unchanged on Wednesday, July 30, 2025. (Tom Williams/CQ-Roll Call, Inc via Getty Images)

Treasury Official Backs Fed Rate Cuts In 2026, Expects US Economy To Grow Around 3% Next Year: Report

He argued that sustained supply-side improvements could contain inflation, despite solid GDP growth.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ stock price, news, financials, current price, message board, forum, community insights, and trading ideas, Join 10 million+ investors and traders tracking markets in real-time on Stocktwits.

QQQ
Invesco QQQ Trust Series 1

Feed

News

Sentiment

Fundamentals

Info

Latest QQQ News

QQQInvesco QQQ Trust Series 1